LIVE: FDA Vaccines Advisory Committee Holds Meeting on COVID-19 Vaccines

Live News Network
1.4K followers
30 Video Views·May 28, 2026
The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) meets in open session at 8:30 a.m. ET on May 28 to discuss and make recommendations on the selection of the 2026–2027 formula for COVID-19 vaccines in the United States.
AI Generated·May contain errors
Video Summary
AI GeneratedThe 192nd VRBPAC meeting focused on recommending the 2026-2027 COVID-19 vaccine composition for the U.S. After reviewing epidemiological data and immunogenicity studies, the committee overwhelmingly voted to recommend the JN.1 lineage XFG variant for a monovalent vaccine, citing its predominance and superior neutralization breadth.
